Postoplan Raises $1.5M In Funding
24 Jul, 2021
– Reacta Biotech from Deeside, North Wales, UK, raised £2.9m in funding.
– The round was led by Praetura Ventures with participation from existing shareholders including the Development Bank of Wales, Perscitus, Jon Moulton’s family office, and Reacta’s management team.
– The new investment will be used to scale up the company’s current product range, expand its team of specialists and expedite work on enhanced packaging solutions.